NURS6630 Adult Geriatric Depression Hispanic Male With MDD Paper

NURS6630 Adult Geriatric Depression Hispanic Male With MDD Paper

NURS6630 Adult Geriatric Depression Hispanic Male With MDD Paper

NURS 6630 Week 3 Assignment

Assessing and Treating Adult and Geriatric Clients With Mood Disorders

Modern understanding of mood disorders has been altered by advances in genetics and epigenetics, leading to new evidence-based treatments. As a psychiatric mental health nurse practitioner, it is crucial for you to keep up with the most recent research and industry best practices. You should think about the best methods for diagnosing and treating geriatric and adult patients who present with mood disorders as you complete this assignment. NURS6630 Adult Geriatric Depression Hispanic Male With MDD Paper

Required Readings

Note: All Stahl resources can be accessed through the Walden Library using this link. This link will take you to a log-in page for the Walden Library. Once you log into the library, the Stahl website will appear.NURS6630 Adult Geriatric Depression Hispanic Male With MDD Paper

Stahl, S. M. (2013). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). New York, NY: Cambridge University Press.

Note: To access the following chapters, click on the Essential Psychopharmacology, 4th ed tab on the Stahl Online website and select the appropriate chapter. Be sure to read all sections on the left navigation bar for each chapter.

Chapter 6, “Mood Disorders”

Stahl, S. M. (2014b). The prescriber’s guide (5th ed.). New York, NY: Cambridge University Press.

Note: To access the following medications, click on the The Prescriber’s Guide, 5th ed tab on the Stahl Online website and select the appropriate medication. NURS6630 Adult Geriatric Depression Hispanic Male With MDD Paper

Review the following medications:

  • amitriptyline
  • bupropion
  • citalopram

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author.

Note: Retrieved from Walden Library databases.

Montgomery, S. A., & Asberg, M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382-389. Retrieved from https://www.researchgate.net/profile/Marie_Asberg/publication/22697065_A_New_Depression_Scale_Designed_to_be_Sensitive_to_Change/links/09e41513f85c708fee000000.pdf

Required Media

Laureate Education. (2016g). Case study: An elderly Hispanic man with major depressive disorder [Interactive media file]. Baltimore, MD: Author.

Note: This case study will serve as the foundation for this week’s Assignment.

To prepare for this Assignment:

Review this week’s Learning Resources. Consider how to assess and treat adult and geriatric clients requiring antidepressant therapy.

The Assignment

Examine Case Study: An Elderly Hispanic Man With Major Depressive Disorder. You will be asked to make three decisions concerning the medication to prescribe to this client. Be sure to consider factors that might impact the client’s pharmacokinetic and pharmacodynamic processes.

At each decision point stop to complete the following:

Decision #1

  1. Which decision did you select?
  2. Why did you select this decision? Support your response with evidence and references to the Learning Resources. NURS6630 Adult Geriatric Depression Hispanic Male With MDD Paper
  3. What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources.
  4. Explain any difference between what you expected to achieve with Decision #1 and the results of the decision. Why were they different?

Decision #2

  1. Why did you select this decision? Support your response with evidence and references to the Learning Resources.
  2. What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources.
  3. Explain any difference between what you expected to achieve with Decision #2 and the results of the decision. Why were they different?

Decision #3

  1. Why did you select this decision? Support your response with evidence and references to the Learning Resources.
  2. What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources.
  3. Explain any difference between what you expected to achieve with Decision #3 and the results of the decision. Why were they different?
  4. Also include how ethical considerations might impact your treatment plan and communication with clients.

BELOW IS THE INFO OF THE CASE STUDY

Adult/Geriatric Depression Hispanic Male With MDD

BACKGROUND INFORMATION

The client is a 32-year-old Hispanic American male who came to the United States when he was in high school with his father. His mother died back in Mexico when he was in school. He presents today to the PMHNPs office for an initial appointment for complaints of depression. The client was referred by his PCP after “routine” medical work-up to rule out an organic basis for his depression. He has no other health issues with the exception of some occasional back pain and “stiff” shoulders which he attributes to his current work as a laborer in a warehouse. NURS6630 Adult Geriatric Depression Hispanic Male With MDD Paper

SUBJECTIVE

During today’s clinical interview, client reports that he always felt like an outsider as he was “teased” a lot for being “black” in high school. States that he had few friends, and basically kept to himself.

He describes his home life as “good.” Stating “Dad did what he could for us, there were 8 of us.” He also reports a remarkably diminished interest in engaging in usual activities, states that he has gained 15 pounds in the last 2 months. He is also troubled with insomnia which began about 6 months ago, but have been progressively getting worse. He does report poor concentration which he reports is getting in “trouble” at work.

MENTAL STATUS EXAM

The client is alert, oriented to person, place, time, and event. He is casually dressed. Speech is clear, but soft. He does not readily make eye contact, but when he does, it is only for a few moments. He is endorsing feelings of depression. Affect is somewhat constricted, but improves as the clinical interview progresses.

He denies visual or auditory hallucinations, no overt delusional or paranoid thought processes readily apparent. Judgment and insight appear grossly intact. He is currently denying suicidal or homicidal ideation. The PMHNP administers the “Montgomery- Asberg Depression Rating Scale (MADRS)” and obtained a score of 51 (indicating severe depression). NURS6630 Adult Geriatric Depression Hispanic Male With MDD Paper

RESOURCES

§ Montgomery, S. A., & Asberg, M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382-389.

Decision Point One

Select what the PMHNP should do:

Begin zoloft 25 mg orally daily

Begin Effexor XR 37.5 mg orally daily

Begin Phenelzine 15 mg orally TID

Decision Point One answer that I selected

Begin Effexor XR 37.5 mg orally daily

AFTER TAKEN EFFEXOR XR 37.5MG BELOW IS THE RESULTS OF DECISION POINT ONE

  • Client returns to clinic in four weeks
  • Client reports that there is no change in depressive symptoms at all

Decision Point Two NURS6630 Adult Geriatric Depression Hispanic Male With MDD Paper

Select what the PMHNP should do next:

Increase dose to 75 mg of Effexor XR orally daily

Change to Cymbalta 30 mg orally daily

Augment with an atypical antipsychotic

Decision Point Two

Increase dose to 75 mg of Effexor XR orally daily

RESULTS OF DECISION POINT TWO

  • Client returns to clinic in four weeks
  • Client reports an improvement in depressive symptoms
  • Montgomery- Asberg Depression Rating Scale (MADRS) decreased from 51 to 38 (25% reduction)

Decision Point Three

Select what the PMHNP should do next:

NURS6630 Adult Geriatric Depression Hispanic Male With MDD Paper

Continue same dose of medication

Augment with Wellbutrin XL 150 mg orally daily

Decision Point Three

Increase dose to 112.5 mg orally daily

Guidance to Student

At this point, the PMHNP would have two options to discuss with the client: either continue the present dosage of the medication if the client is feeling better and isn’t complaining of any side effects, or change the medication. At this stage, the dose can also be raised, but the PMHNP must warn the client about potential negative effects.

Since Effexor has not yet achieved its maximal dose (75 mg is still a relatively low dose), and is merely showing SSRI-like qualities, the use of an augmenting medication is not acceptable at this time (recall that at lower doses, Effexor exerts a greater effect on serotonergic receptors than norepinephrine at low doses). NURS6630 Adult Geriatric Depression Hispanic Male With MDD Paper